fulminant hepatitis
Jump to navigation
Jump to search
Introduction
Appearance of severe liver injury with coagulopathy & hepatic encephalopathy within 8 weeks of the onset of hepatitis in a previously healthy individual.
Etiology
- hepatitis B
- hepatitis A
- cryptogenic hepatitis (non A, B or C)
- drug-induced liver disease
- parvovirus B19
Epidemiology
- 2000 cases yearly in USA
- 6% of liver-related deaths
Complications
- mortality is 30-85% depending upon cause
Management
- drug-induced fulminant hepatitis carries a very poor prognosis, except for acetaminophen-induced in which spontaneous recovery generally occurs
- liver transplantation
- refer early
- indications:
- spontaneous recovery is unlikely
- transplant recovery is probable
- treat infections
- treat hemodynamic abnormalities
- minimize brain edema
More general terms
Additional terms
References
- ↑ Medical Knowledge Self Assessment Program (MKSAP) 11, American College of Physicians, Philadelphia 1998